When was Kynmobi approved by the FDA?

Written by Teresa Carvalho, MS | May 24, 2023

When was Kynmobi approved by the FDA?

Category: Kynmobi

The U.S. Food and Drug Administration (FDA) approved Kynmobi in May 2020 for the treatment of short-term, intermittent off episodes in people with Parkinson’s disease. This made Kynmobi the first under-the-tongue or sublingual treatment for Parkinson’s off episodes to be approved in the U.S.

About the Author

Teresa Carvalho, MS Teresa holds her Master of Science in cell and molecular biology from Coimbra University, Portugal. She was a researcher and science communicator for several years at the Institute for Research and Innovation in Health in Oporto, Portugal. From 2013, she has held a fellowship working with Pulmonary Hypertension Europe as a patient advocate, social media/website manager, public relations officer, and translator. Her work has been focused on providing patients access to treatments, raising awareness for pulmonary hypertension, and promoting patient empowerment.